HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Katayama Selected Research

Messenger RNA (mRNA)

1/2022CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop.
1/2021Protein citrullination as a source of cancer neoantigens.
12/2020The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.
1/2020NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer Cells through CPEB3-Mediated Translational Repression.
1/2020Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Katayama Research Topics

Disease

29Neoplasms (Cancer)
05/2022 - 06/2008
5Adenocarcinoma
01/2022 - 11/2017
5Neoplasm Metastasis (Metastasis)
10/2021 - 01/2019
5Breast Neoplasms (Breast Cancer)
05/2021 - 08/2015
4Adenocarcinoma of Lung
05/2022 - 12/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 06/2008
4Lung Neoplasms (Lung Cancer)
01/2018 - 12/2016
3Carcinogenesis
05/2021 - 12/2020
3Triple Negative Breast Neoplasms
01/2020 - 08/2015
3Cysts
09/2012 - 08/2007
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2021 - 01/2017
2Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 01/2020
2Infections
01/2016 - 11/2010
2Inflammation (Inflammations)
12/2009 - 04/2009
1Rectal Neoplasms (Rectal Cancer)
07/2021
1Noninfiltrating Intraductal Carcinoma (DCIS)
05/2021
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Colonic Neoplasms (Colon Cancer)
12/2020
1Polyps
12/2020
1Chromosomal Instability (Chromosome Stability)
12/2020
1Microsatellite Instability
12/2020
1Type 2 Diabetes Mellitus (MODY)
11/2020
1Ovarian Neoplasms (Ovarian Cancer)
02/2020
1Retinoblastoma (Glioblastoma, Retinal)
01/2020
1Bronchiolitis Obliterans Syndrome
01/2020

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
05/2022 - 06/2008
8AntigensIBA
05/2021 - 08/2015
7Biomarkers (Surrogate Marker)IBA
07/2021 - 01/2016
5Messenger RNA (mRNA)IBA
01/2022 - 01/2020
5ProteomeIBA
05/2020 - 06/2008
4AutoantibodiesIBA
05/2021 - 08/2015
4Neoplasm Antigens (Tumor Antigens)IBA
05/2021 - 01/2019
4Immunoglobulins (Immunoglobulin)IBA
01/2021 - 01/2019
4Peptides (Polypeptides)IBA
01/2021 - 01/2017
3Biological ProductsIBA
01/2022 - 06/2008
3Small Interfering RNA (siRNA)IBA
10/2020 - 12/2014
3Drinking WaterIBA
01/2016 - 01/2008
2Irinotecan (Camptosar)FDA LinkGeneric
01/2022 - 11/2020
2Blood Proteins (Serum Proteins)IBA
07/2021 - 01/2019
2Long Noncoding RNAIBA
12/2020 - 10/2020
2Conditioned Culture MediaIBA
05/2020 - 12/2016
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020 - 01/2020
2Estrogen ReceptorsIBA
01/2020 - 08/2015
2Peptide Hydrolases (Proteases)FDA Link
01/2020 - 01/2020
2Pharmaceutical PreparationsIBA
01/2020 - 01/2016
2Complement System Proteins (Complement)IBA
01/2019 - 11/2017
2Leukocyte Elastase (Neutrophil Elastase)IBA
01/2017 - 01/2017
2WastewaterIBA
05/2016 - 06/2012
2RNA (Ribonucleic Acid)IBA
11/2010 - 06/2008
1EnzymesIBA
05/2022
1kynureninaseIBA
05/2022
1KynurenineIBA
05/2022
1Tryptophan (L-Tryptophan)FDA Link
05/2022
1HydrolasesIBA
01/2022
1Carboxylesterase (Hydrolase S)IBA
01/2022
1Apoptosis Regulatory ProteinsIBA
01/2022
1Serine (L-Serine)FDA Link
01/2022
1ProdrugsIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1Thyroid Nuclear Factor 1IBA
01/2022
1Epoxide HydrolasesIBA
01/2022
1Protein Isoforms (Isoforms)IBA
10/2021
1Proline (L-Proline)FDA Link
10/2021
1Alanine (L-Alanine)FDA Link
10/2021
1Cathepsin BIBA
07/2021
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
07/2021
1Insulin-Like Growth Factor Binding Protein 4IBA
07/2021
1Immunoglobulin G (IgG)IBA
05/2021
1EpitopesIBA
05/2021
1Protein-Arginine Deiminase Type 2IBA
01/2021
1Protein-Arginine DeiminasesIBA
01/2021
1Antigen-Antibody Complex (Immune Complex)IBA
01/2021
1CitrullineIBA
01/2021
1AzoxymethaneIBA
12/2020
1Aurora Kinase BIBA
12/2020
1Dextran SulfateIBA
12/2020
1folfirinoxIBA
11/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2020
1Leucovorin (Folinic Acid)FDA Link
11/2020
1Fluorouracil (Carac)FDA LinkGeneric
11/2020
1Recombinant ProteinsIBA
02/2020
1UbiquitinIBA
01/2020
1N',N''-diacetylspermineIBA
01/2020
1Bortezomib (Velcade)FDA Link
01/2020
1SpermineIBA
01/2020
1Spermine SynthaseIBA
01/2020
1Proteasome InhibitorsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1PolyaminesIBA
01/2020
1amsonic acid (DAS)IBA
01/2020
1Retinoblastoma ProteinIBA
01/2020
1Progesterone Receptors (Progesterone Receptor)IBA
01/2020
13' Untranslated Regions (3' UTR)IBA
01/2020

Therapy/Procedure

4Therapeutics
12/2020 - 01/2016
2Drug Therapy (Chemotherapy)
03/2020 - 01/2017
2Immunotherapy
01/2017 - 01/2017
1Neoadjuvant Therapy
07/2021
1Combination Drug Therapy (Combination Chemotherapy)
11/2020
1Precision Medicine
03/2020